Y010-0627 Screening compound: 2-[2-(1H-indol-3-yl)acetamido]-N-(2-methylphenyl)-2-phenylacetamide

Y010-0627 Screening compound: 2-[2-(1H-indol-3-yl)acetamido]-N-(2-methylphenyl)-2-phenylacetamide
Y010-0627 Screening compound: 2-[2-(1H-indol-3-yl)acetamido]-N-(2-methylphenyl)-2-phenylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y010-0627
2-[2-(1H-indol-3-yl)acetamido]-N-(2-methylphenyl)-2-phenylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y010-0627

Molecular Formula

C25H23N3O2 (C25 H23 N3 O2)

Compound Name

2-[2-(1H-indol-3-yl)acetamido]-N-(2-methylphenyl)-2-phenylacetamide

IUPAC name

2-[2-(1H-indol-3-yl)acetamido]-N-(2-methylphenyl)-2-phenylacetamide

SMILES

Cc(cccc1)c1NC(C(c1ccccc1)NC(Cc1c[nH]c2c1cccc2)=O)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

397.48

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

3.781

Distribution Coefficient, logD

3.781

Water Solubility, LogSw

-4.03

Polar Surface Area

56.055

Acid Dissociation Constant (pKa)

10.76

Base Dissociation Constant (pKb)

1.44

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

12.00

Y010-0627 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Indole Derivatives (10091 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Receptor-type Protein Tyrosine Phosphatases Library (3746 compounds)

Included in 1.7M Stock Database

Structure:
  • Cyclic compounds
Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Digestive system
  • Nervous system
  • Female
  • Metabolic
  • Endocrine
Targets:
  • Proteases
  • Phosphatases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with Y010-0627 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y010-0627?
Check Price and Availability of Y010-0627, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y010-0627 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y010-0627
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y010-0627
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y010-0627 available by request